ferric citrate has been researched along with Iron Overload in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (61.54) | 24.3611 |
2020's | 4 (30.77) | 2.80 |
Authors | Studies |
---|---|
Blasco-Conesa, MP; Ganesh, BP; Guzman, G; Lai, YJ; McCullough, LD; Monga, S; Moruno-Manchon, JF; Noh, B; Rahman, SM; Ritzel, R; Urayama, A | 1 |
Chen, Z; Cheng, A; Huang, C; Lao, C; Liu, W; Luo, Q; Ma, W; Shi, L; Shi, R; Xia, Y; Zou, Y | 1 |
Aslam, N; Basdeo, LM; Govani, M; Wadei, HM | 1 |
Covic, AC; Floege, J; Funk, F; Ketteler, M; Rastogi, A; Sprague, SM; Walpen, S | 1 |
Chen, Z; Huang, C; Lao, C; Liu, W; Luo, Q; Ma, W; Xia, Y | 1 |
Chang, CS; Chang, JS; Chang, TY; Chen, SH; Lee, YC; Liu, KL; Su, CT | 1 |
Masereeuw, R; Swinkels, DW; van Raaij, SEG; van Swelm, RPL | 1 |
Camacho, A; Cancela, ML; Ea, HK; Gavaia, PJ; Pinto, IJ; Porto, G; Simão, M | 1 |
Bino, A; Ganz, T; Salusky, IB | 1 |
Vaziri, ND | 1 |
Eccleston, J; Evans, P; Hider, RC; Kayyali, R; Porter, JB | 1 |
Jiang, Y; Li, YM; Liu, PJ; Lü, HR; Mu, J; Xiao, X; Xie, F; Xu, XN; Zhao, MF; Zhu, HB | 1 |
Arnaud, J; Bolder, U; Brissot, P; Hofmann, AF; Schteingart, CD | 1 |
2 review(s) available for ferric citrate and Iron Overload
Article | Year |
---|---|
Mechanism of Action and Clinical Attributes of Auryxia
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Cardiovascular Diseases; Chelating Agents; Clinical Trials as Topic; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Iron; Iron Overload; Phosphates; Renal Insufficiency, Chronic; Risk Factors; Treatment Outcome | 2019 |
Safety Issues in Iron Treatment in CKD.
Topics: Anemia, Iron-Deficiency; Cardiovascular Diseases; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Disease Progression; Ferric Compounds; Hematinics; Humans; Iron Compounds; Iron Overload; Kidney Failure, Chronic; Oxidative Stress; Reactive Oxygen Species; Renal Dialysis; Renal Insufficiency, Chronic | 2016 |
11 other study(ies) available for ferric citrate and Iron Overload
Article | Year |
---|---|
Iron overload induces cerebral endothelial senescence in aged mice and in primary culture in a sex-dependent manner.
Topics: Aged; Aging; Animals; Cellular Senescence; Endothelial Cells; Female; Humans; Iron; Iron Overload; Male; Mice; Receptors, Cell Surface | 2023 |
Iron overload resulting from the chronic oral administration of ferric citrate induces parkinsonism phenotypes in middle-aged mice.
Topics: Animals; Brain; Disease Models, Animal; Ferric Compounds; Iron Overload; Male; Mice; Oxidative Stress; Parkinsonian Disorders | 2019 |
Can ferric citrate lead to iron overload in peritoneal dialysis patients?
.
Topics: Aged; Female; Ferric Compounds; Humans; Hyperphosphatemia; Iron Overload; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis | 2020 |
Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation.
Topics: Administration, Oral; Anemia; Animals; Drug Combinations; Female; Ferric Compounds; Inflammation; Iron; Iron Overload; Kinetics; Male; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sucrose; Tissue Distribution | 2020 |
Iron Overload Resulting from the Chronic Oral Administration of Ferric Citrate Impairs Intestinal Immune and Barrier in Mice.
Topics: Administration, Oral; Animals; Ferric Compounds; Intestinal Mucosa; Intestines; Iron Overload; Mice | 2021 |
Ferric Citrate Supplementation Reduces Red-Blood-Cell Aggregation and Improves CD163+ Macrophage-Mediated Hemoglobin Metabolism in a Rat Model of High-Fat-Diet-Induced Obesity.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Diet, High-Fat; Dietary Supplements; Erythrocyte Aggregation; Ferric Compounds; Hemoglobins; Iron Overload; Liver; Macrophages; Male; Obesity; Peptide Fragments; Rats, Sprague-Dawley; Receptors, Cell Surface | 2018 |
Inhibition of Nrf2 alters cell stress induced by chronic iron exposure in human proximal tubular epithelial cells.
Topics: Alkaloids; Cell Line; Dose-Response Relationship, Drug; Ferric Compounds; Ferritins; Heme Oxygenase-1; Humans; Iron Overload; Kidney Diseases; Kidney Tubules, Proximal; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Time Factors; Transcription Factor CHOP | 2018 |
Intracellular iron uptake is favored in Hfe-KO mouse primary chondrocytes mimicking an osteoarthritis-related phenotype.
Topics: Aggrecans; Animals; Cartilage, Articular; Cation Transport Proteins; Cell Differentiation; Chondrocytes; Collagen Type I; Disease Models, Animal; Extracellular Matrix; Female; Ferric Compounds; Ferritins; Gene Expression Regulation; Hemochromatosis; Hemochromatosis Protein; Humans; Iron; Iron Overload; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteoarthritis; Oxidoreductases; Primary Cell Culture; Receptors, Transferrin; Sex-Determining Region Y Protein; Signal Transduction; SOX9 Transcription Factor | 2019 |
Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone.
Topics: Adult; Chromatography, High Pressure Liquid; Deferiprone; Deferoxamine; Female; Ferric Compounds; Humans; Iron; Iron Chelating Agents; Iron Overload; Kinetics; Male; Pyridones; Siderophores; Thalassemia; Transferrin; Transfusion Reaction | 2010 |
[In vitro effect of iron overload on bone marrow cell function by inducing the reactive oxygen species].
Topics: Bone Marrow Cells; Cells, Cultured; Culture Media; Erythrocytes; Ferric Compounds; Hematopoiesis; Humans; Iron Overload; Reactive Oxygen Species | 2011 |
Intestinal absorption and enterohepatic cycling of biliary iron originating from plasma non-transferrin-bound iron in rats.
Topics: Animals; Bile; Deferiprone; Ferric Compounds; Injections, Intravenous; Intestinal Absorption; Intestinal Mucosa; Iron; Iron Chelating Agents; Iron Overload; Liver; Male; Pyridones; Rats; Rats, Sprague-Dawley; Reference Values; Transferrin | 1997 |